229 related articles for article (PubMed ID: 20737298)
1. The use of cell-delivered gene therapy for the treatment of HIV/AIDS.
Symonds GP; Johnstone HA; Millington ML; Boyd MP; Burke BP; Breton LR
Immunol Res; 2010 Dec; 48(1-3):84-98. PubMed ID: 20737298
[TBL] [Abstract][Full Text] [Related]
2. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
Allers K; Schneider T
Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
[TBL] [Abstract][Full Text] [Related]
3. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
Lai Y
Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic-stem-cell-based gene therapy for HIV disease.
Kiem HP; Jerome KR; Deeks SG; McCune JM
Cell Stem Cell; 2012 Feb; 10(2):137-47. PubMed ID: 22305563
[TBL] [Abstract][Full Text] [Related]
5. Positive results with autologous transplant of ZFN-modified CD4 T-cells: a step toward a practical, functional cure for HIV.
AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22023317
[No Abstract] [Full Text] [Related]
6. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
Anderson JS; Javien J; Nolta JA; Bauer G
Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
[TBL] [Abstract][Full Text] [Related]
7. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
[TBL] [Abstract][Full Text] [Related]
8. Can HIV be cured with stem cell therapy?
Deeks SG; McCune JM
Nat Biotechnol; 2010 Aug; 28(8):807-10. PubMed ID: 20697404
[No Abstract] [Full Text] [Related]
9. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
[TBL] [Abstract][Full Text] [Related]
10. CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.
Sebastian NT; Zaikos TD; Terry V; Taschuk F; McNamara LA; Onafuwa-Nuga A; Yucha R; Signer RAJ; Riddell J; Bixby D; Markowitz N; Morrison SJ; Collins KL
PLoS Pathog; 2017 Jul; 13(7):e1006509. PubMed ID: 28732051
[TBL] [Abstract][Full Text] [Related]
11. Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G
J Gene Med; 2018 Feb; 20(2-3):e3006. PubMed ID: 29552747
[TBL] [Abstract][Full Text] [Related]
12. The emerging race to cure HIV infections.
Cohen J
Science; 2011 May; 332(6031):784-5, 787-9. PubMed ID: 21566173
[No Abstract] [Full Text] [Related]
13. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
14. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice.
Hofer U; Henley JE; Exline CM; Mulhern O; Lopez E; Cannon PM
J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S160-4. PubMed ID: 24151324
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.
Peterson CW; Younan P; Jerome KR; Kiem HP
Gene Ther; 2013 Jul; 20(7):695-702. PubMed ID: 23364313
[TBL] [Abstract][Full Text] [Related]
17. Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?
Younan P; Kowalski J; Kiem HP
Mol Ther; 2014 Feb; 22(2):257-264. PubMed ID: 24220323
[TBL] [Abstract][Full Text] [Related]
18. Coreceptor-Based Hematopoietic Stem Cell Gene Therapy for HIV Disease.
Hu J; Feng Y; Ma P; Lai Y
Curr Stem Cell Res Ther; 2019; 14(7):591-597. PubMed ID: 31120000
[TBL] [Abstract][Full Text] [Related]
19. Controlling HIV infection: HIV co-receptor gets the finger.
Kelleher AD; Purcell DF
Immunol Cell Biol; 2008; 86(8):641-2. PubMed ID: 18779839
[No Abstract] [Full Text] [Related]
20. Stem cell-based therapies for HIV/AIDS.
Pernet O; Yadav SS; An DS
Adv Drug Deliv Rev; 2016 Aug; 103():187-201. PubMed ID: 27151309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
